BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37178584)

  • 1. A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.
    Cui Y; Cheng Y; Huang W; Liu J; Zhang X; Bu M; Li X
    Arch Oral Biol; 2023 Aug; 152():105719. PubMed ID: 37178584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
    Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
    J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
    Zhao G; Li CX; Guo C; Zhu H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
    Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
    BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
    Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
    Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Evaluation for Oral Squamous Cell Carcinoma: A Novel Method Based on m
    Xu L; Yu C; Du XJ
    Curr Med Sci; 2022 Aug; 42(4):841-846. PubMed ID: 35963950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
    Qi L; Tang Z
    Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an endoplasmic reticulum stress-related prognostic risk model with excellent prognostic and clinical value in oral squamous cell carcinoma.
    Cheng M; Fan X; He M; Dai X; Liu X; Hong J; Zhang L; Liao L
    Aging (Albany NY); 2023 Aug; 15(19):10010-10030. PubMed ID: 37647077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.
    Huang Z; Lu Y; Wang W; Xie N; Yi C; Xiong G; Xu X; Zhang M; Wang C
    J Oral Pathol Med; 2023 May; 52(5):372-380. PubMed ID: 36135715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel T-cell proliferation-associated regulator signature pre-operatively predicted the prognostic of bladder cancer.
    Hou J; Wen X; Lu Z; Wu G; Yang G; Tang C; Qu G; Xu Y
    Front Immunol; 2022; 13():970949. PubMed ID: 36211359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
    Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
    Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.